Let's explore investing in Medocta.
Platform growth
1. Introduce yourself
Tell us about your investment focus and what interests you about Medocta.
2. Explore the fit
We can discuss the platform, market and areas you would like to understand.
3. Agree the next step
If there is a fit, agree what information to share and how to continue.
These are exploratory conversations. Scope, availability and terms are discussed individually.
For organisations, sponsors and delivery partners
Agree what success means before a programme starts.
For a screening programme, discuss how people will receive support after checks, how progress will be reviewed and what evidence will inform changes or expansion.
- Screen
- Support
- Measure
- Learn
- Improve
- Scale
- Goals and follow-up
- Agree the starting assessment, relevant health and wellbeing measures, review dates and who is responsible for follow-up.
- Access and health outcomes
- Review participation, completed referrals and continued support separately from changes in health or wellbeing.
- Evidence for the next decision
- Use findings, participant feedback and delivery capacity to decide whether to continue, change or expand a programme.
Reporting scope is agreed before launch. Programme reports should use aggregate data that protects identities, state participant numbers and review periods, and explain missing follow-up data. Individual medical records are not programme reports.
Read our approach to measurable progress